- Home
- HOMB vs LNTH Comparison
HOMB vs LNTH Comparison
Compare HOMB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOMB
- LNTH
- Stock Information
- Founded
- HOMB 1998
- LNTH 1956
- Country
- HOMB United States
- LNTH United States
- Employees
- HOMB N/A
- LNTH N/A
- Industry
- HOMB Major Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HOMB Finance
- LNTH Health Care
- Exchange
- HOMB Nasdaq
- LNTH Nasdaq
- Market Cap
- HOMB 6.0B
- LNTH 6.3B
- IPO Year
- HOMB 2006
- LNTH 2015
- Fundamental
- Price
- HOMB $29.77
- LNTH $92.66
- Analyst Decision
- HOMB Buy
- LNTH Strong Buy
- Analyst Count
- HOMB 4
- LNTH 5
- Target Price
- HOMB $30.50
- LNTH $130.60
- AVG Volume (30 Days)
- HOMB 733.9K
- LNTH 999.7K
- Earning Date
- HOMB 01-15-2025
- LNTH 11-06-2024
- Dividend Yield
- HOMB 2.56%
- LNTH N/A
- EPS Growth
- HOMB N/A
- LNTH 304.57
- EPS
- HOMB 1.93
- LNTH 6.02
- Revenue
- HOMB $967,420,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- HOMB N/A
- LNTH $19.56
- Revenue Next Year
- HOMB $1.74
- LNTH $3.94
- P/E Ratio
- HOMB $15.76
- LNTH $15.39
- Revenue Growth
- HOMB N/A
- LNTH 24.15
- 52 Week Low
- HOMB $22.38
- LNTH $50.20
- 52 Week High
- HOMB $32.91
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- HOMB 42.88
- LNTH 51.56
- Support Level
- HOMB $30.12
- LNTH $91.20
- Resistance Level
- HOMB $30.59
- LNTH $95.04
- Average True Range (ATR)
- HOMB 0.58
- LNTH 2.48
- MACD
- HOMB -0.28
- LNTH 1.13
- Stochastic Oscillator
- HOMB 6.87
- LNTH 71.39
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality, and a solid balance sheet. The bank's main source of net revenue is net interest income.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.